While overexpression of COX2 is both a signature and a mediator of tumor progression and metastasis in a variety of epithelial cancers (Harris et al., 2006), there are no data in the literature that demonstrate a direct effect of the PI3K/AKT pathway on the COX protein family. The gene discussed is PTGS2; the disease is neoplasm.